Compare, Analyse with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ZIM LABORATORIES   ACTAVIS
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-21
ACTAVIS
Dec-18
ZIM LABORATORIES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs13114,534-   
Low Rs539,749-   
Sales per share (Unadj.) Rs189.23,565.1-  
Earnings per share (Unadj.) Rs4.5-1,148.3-  
Cash flow per share (Unadj.) Rs14.2375.7-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs99.014,704.5-  
Shares outstanding (eoy) m16.24332.60-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.53.4 14.3%   
Avg P/E ratio x20.5-10.6 -193.4%  
P/CF ratio (eoy) x6.532.3 20.0%  
Price / Book Value ratio x0.90.8 112.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,4974,038,273 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m3580-   
Avg. sales/employee Rs ThNM70,163.4-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-22,599.7-  
INCOME DATA
Net Sales Rs m3,0731,185,762 0.3%  
Other income Rs m2322,676 0.1%   
Total revenues Rs m3,0961,208,437 0.3%   
Gross profit Rs m34631,073 1.1%  
Depreciation Rs m158506,887 0.0%   
Interest Rs m10968,425 0.2%   
Profit before tax Rs m102-521,564 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0133,020 0.0%   
Tax Rs m29-6,610 -0.4%   
Profit after tax Rs m73-381,934 -0.0%  
Gross profit margin %11.32.6 429.5%  
Effective tax rate %28.51.3 2,247.3%   
Net profit margin %2.4-32.2 -7.4%  
BALANCE SHEET DATA
Current assets Rs m1,918486,337 0.4%   
Current liabilities Rs m1,420430,230 0.3%   
Net working cap to sales %16.24.7 342.0%  
Current ratio x1.41.1 119.4%  
Inventory Days Days1620 80.2%  
Debtors Days Days85866 1,294.4%  
Net fixed assets Rs m1,304134,222 1.0%   
Share capital Rs m1620-   
"Free" reserves Rs m1,4450-   
Net worth Rs m1,6084,890,713 0.0%   
Long term debt Rs m2181,722,197 0.0%   
Total assets Rs m3,2227,645,297 0.0%  
Interest coverage x1.9-6.6 -29.3%   
Debt to equity ratio x0.10.4 38.6%  
Sales to assets ratio x1.00.2 614.9%   
Return on assets %5.7-4.1 -137.9%  
Return on equity %4.6-7.8 -58.3%  
Return on capital %11.6-4.8 -239.1%  
Exports to sales %67.40-   
Imports to sales %4.10-   
Net fx Rs m2,0120-   
CASH FLOW
From Operations Rs m319423,628 0.1%  
From Investments Rs m-59232,728 -0.0%  
From Financial Activity Rs m-260-727,072 0.0%  
Net Cashflow Rs m-1-70,363 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 75.11 Rs / USD

Compare ZIM LABORATORIES With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ZIM LABORATORIES With: PIRAMAL ENTERPRISES  IPCA LABS  CORAL LAB.  KREBS BIOCHEMICALS  WANBURY  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views On News

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

How to Hit Rs 100 Crore Wealth in Your Lifetime (Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2022
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ZIM LABORATORIES SHARE PRICE


Nov 26, 2021 (Close)

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES 5-YR ANALYSIS

COMPARE ZIM LABORATORIES WITH

MARKET STATS